COMPANY PROFILE
Atoms for Cure GmbH
GmbH (Limited Liability Company)BerlinResearch and experimental development on biotechnology
FOUNDED
2021
Active
TRADE REGISTER
HRB 236162
Berlin (Charlottenburg)
INDUSTRY
Research and experimental development on biotechnology
SIZE CLASS
Small enterprise
Key questions answered
What does the company do?
Ankauf, das Halten und die Verwertung von Patenten im Bereich der Radiopharmazeutischen Chemie und Nuklearmedizin sowie das Consulting im Bereich der Radiopharmazeutischen Chemie und Nuklearmedizin.
Who leads it?
Dr. Hans-Peter Huppert · Managing Director
How large is it?
Small enterprise
How stable is it?
Stability assessment in Plus profile
Business activity
Industry (WZ2008)
Research and experimental development on biotechnology
WZ M72.11
Size class
Small
Industry (WZ2008) (2)
- M72.11Research and experimental development on biotechnology
- M72.19Other research and experimental development on natural sciences and engineering
Business purpose
Ankauf, das Halten und die Verwertung von Patenten im Bereich der Radiopharmazeutischen Chemie und Nuklearmedizin sowie das Consulting im Bereich der Radiopharmazeutischen Chemie und Nuklearmedizin.
Legal essentials
- Register entry
- HRB 236162 (Berlin (Charlottenburg))
- Legal form
- GmbH (Limited Liability Company)
- Founded
- 28 Nov 2021
- Share capital
- €30,000
- VAT ID
- —
- LEI
- 391200A6RTLLAWB1CT32
- Representation rules
- Ist ein Geschäftsführer bestellt, so vertritt er die Gesellschaft allein. Sind mehrere Geschäftsführer bestellt, wird die Gesellschaft gemeinschaftlich durch zwei Geschäftsführer oder durch einen Geschäftsführer in Gemeinschaft mit einem Prokuristen vertreten.
Order shareholder list
The statutory shareholder list (§ 40 GmbHG) straight from the official register portal — who holds which shares.
Available once you sign in
Annual statements
No public annual statements on file.
Signals
Four dimensions from hard data — age, financials, HRB events, compliance. The ratings themselves are shown in the Plus profile only.
- Continuity1Available in Plus profile
- Financials2Available in Plus profile
- Management3Available in Plus profile
- Legal status4Available in Plus profile
Directors & officers
Managing directors
Dr. Hans-Peter Huppert
Managing Director
Research contacts
AI-powered research for publicly available contacts: name, role, phone, email, LinkedIn.
Available once you sign in
Recent news
AI-powered research across press, social media and job postings from the last six months.
Available once you sign in
Commercial register history
No events on file.
Companies with a similar profile
Medianezia GmbH
Inning a.Ammersee
CogniVerde GmbH
Groß-Umstadt
1717 Life Science Ventures GmbH
Hamburg
Full-Life Technologies GmbH
München
3R asset GmbH
Herford
Berking Theranostics UG (haftungsbeschränkt)
Hamburg
OliGo Technologies GmbH
Münster
Deflexion Sole UG (haftungsbeschränkt)
Rheinhausen
Bio-Gram Hematology GmbH
Worms
inventionpharm GmbH
Heilbronn
DEVELOPERS
Programmatic access
Three ways to access this company's data programmatically:
- AGENT-CARD
Freely accessible, no API key required — a compact JSON summary for agents and crawlers.
- API
Full, authenticated data via the Implisense API v2 (API key required).
- MCP
MCP server live at mcp.implisense.com (FastMCP, Bearer auth) — usable with ChatGPT, Claude, and your own agents.
What the Plus profile adds
The same page, fully populated — plus the research services locked here.
- Revenue, result and equity across every available year
- All four signals with rationale and source
- Contact search: names, roles, phone, email, LinkedIn
- Shareholder list from the official register portal
- News research covering the last six months
- The full commercial register history